Endometrial Undifferentiated Carcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Undifferentiated Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone [Phase 2]
Phase 2 trial in recurrent or refractory endometrial cancer evaluating Olaparib with Durvalumab, Cediranib with Durvalumab, Olaparib with Ca…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer [Phase 3]
Phase 3 trial evaluating adding pembrolizumab to paclitaxel and carboplatin for stage III-IV or recurrent endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Onapristone and Anastrozole for refractory hormone receptor-positive endometrial cancer…
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer [Phase 2, Phase 3]
Phase 2/3 trial evaluating paclitaxel and carboplatin with or without metformin in advanced or recurrent endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-06Clinical Trial Update: Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating copanlisib in persistent or recurrent endometrial cancer has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer [Phase 1]
A Phase 1 trial evaluating the combination of dasatinib, paclitaxel, and carboplatin in patients with Stage III-IV or recurrent endometrial …
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial of brivanib alaninate in patients with recurrent or persistent endometrial cancer has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial evaluating dalantercept for recurrent or persistent endometrial cancer has completed and posted results.